Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 106

1.

Plasma exchange and glucocorticoid dosing in the treatment of anti-neutrophil cytoplasm antibody associated vasculitis (PEXIVAS): protocol for a randomized controlled trial.

Walsh M, Merkel PA, Peh CA, Szpirt W, Guillevin L, Pusey CD, De Zoysa J, Ives N, Clark WF, Quillen K, Winters JL, Wheatley K, Jayne D; PEXIVAS Investigators.

Trials. 2013 Mar 14;14:73. doi: 10.1186/1745-6215-14-73.

PMID:
23497590
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Advances in therapy for ANCA-associated vasculitis.

Geetha D, Seo P.

Curr Rheumatol Rep. 2012 Dec;14(6):509-15. doi: 10.1007/s11926-012-0284-0. Review.

PMID:
22895899
[PubMed - indexed for MEDLINE]
3.

B-cell depleting agents for ANCA vasculitides: a new therapeutic approach.

Gómez-Puerta JA, Quintana LF, Stone JH, Ramos-Casals M, Bosch X.

Autoimmun Rev. 2012 Jul;11(9):646-52. doi: 10.1016/j.autrev.2011.11.007. Epub 2011 Nov 21. Review.

PMID:
22146313
[PubMed - indexed for MEDLINE]
4.

Long-term follow-up of patients with severe ANCA-associated vasculitis comparing plasma exchange to intravenous methylprednisolone treatment is unclear.

Walsh M, Casian A, Flossmann O, Westman K, Höglund P, Pusey C, Jayne DR; European Vasculitis Study Group (EUVAS).

Kidney Int. 2013 Aug;84(2):397-402. doi: 10.1038/ki.2013.131. Epub 2013 Apr 24.

PMID:
23615499
[PubMed - indexed for MEDLINE]
5.

Plasma exchange for renal vasculitis and idiopathic rapidly progressive glomerulonephritis: a meta-analysis.

Walsh M, Catapano F, Szpirt W, Thorlund K, Bruchfeld A, Guillevin L, Haubitz M, Merkel PA, Peh CA, Pusey C, Jayne D.

Am J Kidney Dis. 2011 Apr;57(4):566-74. doi: 10.1053/j.ajkd.2010.10.049. Epub 2010 Dec 30. Review.

PMID:
21194817
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Early plasma exchange improves outcome in PR3-ANCA-positive renal vasculitis.

Gregersen JW, Kristensen T, Krag SR, Birn H, Ivarsen P.

Clin Exp Rheumatol. 2012 Jan-Feb;30(1 Suppl 70):S39-47. Epub 2012 May 10.

PMID:
22510451
[PubMed - indexed for MEDLINE]
7.

Review article: Progress of treatment in ANCA-associated vasculitis.

Jayne D.

Nephrology (Carlton). 2009 Feb;14(1):42-8. doi: 10.1111/j.1440-1797.2009.01101.x. Review.

PMID:
19335843
[PubMed - indexed for MEDLINE]
8.

Small vessel vasculitis.

Brogan P, Eleftheriou D, Dillon M.

Pediatr Nephrol. 2010 Jun;25(6):1025-35. doi: 10.1007/s00467-009-1317-4. Epub 2009 Nov 3. Review.

PMID:
19885685
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Revisiting the classification of clinical phenotypes of anti-neutrophil cytoplasmic antibody-associated vasculitis: a cluster analysis.

Mahr A, Katsahian S, Varet H, Guillevin L, Hagen EC, Höglund P, Merkel PA, Pagnoux C, Rasmussen N, Westman K, Jayne DR; French Vasculitis Study Group (FVSG) and the European Vasculitis Society (EUVAS).

Ann Rheum Dis. 2013 Jun;72(6):1003-10. doi: 10.1136/annrheumdis-2012-201750. Epub 2012 Sep 8.

PMID:
22962314
[PubMed - indexed for MEDLINE]
10.

Novel therapies for anti-neutrophil cytoplasmic antibody-associated vasculitis.

Lee RW, D'Cruz DP.

Drugs. 2008;68(6):747-70. Review.

PMID:
18416584
[PubMed - indexed for MEDLINE]
11.

New advances in the pathogenesis of ANCA-associated vasculitides.

Chen M, Kallenberg CG.

Clin Exp Rheumatol. 2009 Jan-Feb;27(1 Suppl 52):S108-14. Review.

PMID:
19646356
[PubMed - indexed for MEDLINE]
12.

Incidence of malignancy in patients treated for antineutrophil cytoplasm antibody-associated vasculitis: follow-up data from European Vasculitis Study Group clinical trials.

Heijl C, Harper L, Flossmann O, Stücker I, Scott DG, Watts RA, Höglund P, Westman K, Mahr A; European Vasculitis Study Group (EUVAS).

Ann Rheum Dis. 2011 Aug;70(8):1415-21. doi: 10.1136/ard.2010.145250. Epub 2011 May 25. Review.

PMID:
21616914
[PubMed - indexed for MEDLINE]
13.

Renal involvement in anti-neutrophil cytoplasmic autoantibody associated vasculitis.

Sinico RA, Di Toma L, Radice A.

Autoimmun Rev. 2013 Feb;12(4):477-82. doi: 10.1016/j.autrev.2012.08.006. Epub 2012 Aug 16. Review.

PMID:
22921791
[PubMed - indexed for MEDLINE]
14.

ANCA-associated vasculitis: diagnostic and therapeutic strategy.

Ozaki S.

Allergol Int. 2007 Jun;56(2):87-96. Epub 2007 May 1. Review.

PMID:
17460438
[PubMed - indexed for MEDLINE]
Free Article
15.

Treatment of antineutrophil cytoplasmic antibody-associated vasculitis with rituximab.

Cartin-Ceba R, Fervenza FC, Specks U.

Curr Opin Rheumatol. 2012 Jan;24(1):15-23. doi: 10.1097/BOR.0b013e32834d5730. Review.

PMID:
22089095
[PubMed - indexed for MEDLINE]
16.

[ANCA-associated vasculitis].

Holle JU.

Z Rheumatol. 2013 Jun;72(5):445-56. doi: 10.1007/s00393-013-1211-0. German.

PMID:
23743987
[PubMed - indexed for MEDLINE]
17.

The OMERACT core set of outcome measures for use in clinical trials of ANCA-associated vasculitis.

Merkel PA, Aydin SZ, Boers M, Direskeneli H, Herlyn K, Seo P, Suppiah R, Tomasson G, Luqmani RA.

J Rheumatol. 2011 Jul;38(7):1480-6. doi: 10.3899/jrheum.110276.

PMID:
21724720
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Effects of duration of glucocorticoid therapy on relapse rate in antineutrophil cytoplasmic antibody-associated vasculitis: A meta-analysis.

Walsh M, Merkel PA, Mahr A, Jayne D.

Arthritis Care Res (Hoboken). 2010 Aug;62(8):1166-73. doi: 10.1002/acr.20176.

PMID:
20235186
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Plasma exchange in the treatment of Wegener's granulomatosis, microscopic polyangiitis, Churg-Strauss syndrome and renal limited vasculitis.

Casian A, Jayne D.

Curr Opin Rheumatol. 2011 Jan;23(1):12-7. doi: 10.1097/BOR.0b013e32834120c1. Review.

PMID:
21124082
[PubMed - indexed for MEDLINE]
20.

ANCA-associated vasculitides--advances in pathogenesis and treatment.

Chen M, Kallenberg CG.

Nat Rev Rheumatol. 2010 Nov;6(11):653-64. doi: 10.1038/nrrheum.2010.158. Epub 2010 Oct 5. Review.

PMID:
20924413
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk